Figure 3From: Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patientsKaplan-Meier curves for OS and DFS. Patients with high GDH expression had poorer overall survival (A) and poorer disease-free survival (B) rates than patients with low GDH expression.Back to article page